Throughout the document reference is made to devotions pertaining to Mary such as liturgies, processions, hymns, the Marian months, plus many other elements, aspects, and suggestions. Rosarium ...

Shift Up has officially announced the second NIKKE x Evangelion collab during the Special Christmas livestream. Set to release in February 2025, the upcoming event comes with new Nikkes ...

The Lithuanian cardinal, elevated to the College of Cardinals in December 2024, presided over the ceremony at Rome’s preeminent Marian shrine, where the “Bell of the Lost” rang out across ...

Shift Up revealed the next new character to debut in Goddess of Victory: NIKKE, and it will be the Missilis Military Research (MMR) General Manager Mana. She will be the star of the Wisdom Spring ...

Moderna made a lot of money during the pandemic, but its post-pandemic prospects look bleak. Sales in 2025 could be down more than half from 2024 levels, according to Moderna's latest guidance ...

Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

Moderna projects $1.5 billion-$2.5 billion in 2025 revenue, with cash and investments estimated at $6 billion by year-end. 2024 product sales are approximately $3 billion-$3.1 billion, driven by $ ...

Earlier this month, Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s lackluster vaccine sales in COVID-19 and respiratory ...

A new Rapi alt and event is coming to Goddess of Victory: NIKKE in 2025, with Rapi: Red Hood taking the stage. Her, her background, and her future will be the focus of the “Cheers to the Past ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have been sliding down over the past few years due to waning demand for the ...